FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease-Reference-Cited by-同舟云学术

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease

Published:2009-01-14 Issue:5 Volume:36 Page:811-822
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Mosconi Lisa,Mistur Rachel,Switalski Remigiusz,Tsui Wai Hon,Glodzik Lidia,Li Yi,Pirraglia Elizabeth,De Santi Susan,Reisberg Barry,Wisniewski Thomas,de Leon Mony J.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-008-1039-z.pdf

Reference33 articles.

1. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurol 1991;41:479–86.

2. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 1999;45:358–68.

3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–44.

4. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease. Eur J Nucl Med 2005;32:486–510.

5. Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology 2003;60:1374–7.

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternate-day fasting improves cognitive and brain energy deficits by promoting ketone metabolism in the 3xTg mouse model of Alzheimer's disease;Experimental Neurology;2024-11

2. Astrocytic Ca²⁺ activation by chemogenetics mitigates the effect of kainic acid‐induced excitotoxicity on the hippocampus;Glia;2024-08-26

3. Tensor Kernel Learning for Classification of Alzheimer’s Conditions using Multimodal Data;2024 International Conference on Multimedia Analysis and Pattern Recognition (MAPR);2024-08-15

4. Advances in Blood Biomarkers for Alzheimer’s Disease: Ultra-Sensitive Detection Technologies and Impact on Clinical Diagnosis;Degenerative Neurological and Neuromuscular Disease;2024-07

5. The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia;BMC Medical Imaging;2024-03-28